# Director, External Quality Control & Stability at Centessa Pharmaceuticals

- Company: Centessa Pharmaceuticals
- What the company does: Patient-Centric Mission. Asset-Centric Approach. We’re pursuing our Orexin Receptor 2 Agonist Program to bring potentially transformative treatment options to patients with sleep-wake, neurological, neurodegenerative and neuropsychiatric disorders.... Backed by Foresite Capital.
- Company website: https://centessa.com
- Type: Startups
- Level: Principal and up
- Location: Boston, MA
- Work setup: On-site
- Posted: 2026-08-27
- Apply by: 2026-10-19
- Apply: https://job-boards.greenhouse.io/centessapharmaceuticalsinc/jobs/6166573004?utm_source=1752vc&utm_medium=careers
- Page: https://www.1752.vc/careers/jobs/centessa-pharmaceuticals-director-external-quality-control-and-stability/

## About the role

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Found on 1752vc Careers, the job board for startup and VC roles.

## What they're looking for

- BS/MS/PhD in Chemistry, Analytical Chemistry, Pharmaceutical Sciences, or related field
- 10+ years quality control and analytical development experience
- Experience developing strategic vision as well as providing tactical support for quality control programs

Tags: Quality

Source: 1752vc Careers, https://www.1752.vc/careers/jobs/centessa-pharmaceuticals-director-external-quality-control-and-stability/